Ben-Oz B, Machour F, Nicola M, Argoetti A, Polyak G, Hanna R
Nat Commun. 2023; 14(1):7628.
PMID: 37993446
PMC: 10665399.
DOI: 10.1038/s41467-023-43495-6.
Trauernicht M, Rastogi C, Manzo S, Bussemaker H, van Steensel B
Nucleic Acids Res. 2023; 51(18):9690-9702.
PMID: 37650627
PMC: 10570033.
DOI: 10.1093/nar/gkad718.
Zong L, Liang Z
Cardiovasc Diagn Ther. 2023; 13(3):609-622.
PMID: 37405018
PMC: 10315422.
DOI: 10.21037/cdt-23-123.
Loffler T, Kruger A, Zirak P, Winterhalder M, Muller A, Fischbach A
Nucleic Acids Res. 2023; 51(2):536-552.
PMID: 36625274
PMC: 9881148.
DOI: 10.1093/nar/gkac1235.
Balasundaram A, George Priya Doss C
Int J Mol Sci. 2022; 23(24).
PMID: 36555140
PMC: 9779389.
DOI: 10.3390/ijms232415499.
At a Crossroads to Cancer: How p53-Induced Cell Fate Decisions Secure Genome Integrity.
Rizzotto D, Englmaier L, Villunger A
Int J Mol Sci. 2021; 22(19).
PMID: 34639222
PMC: 8509445.
DOI: 10.3390/ijms221910883.
DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.
Kara A, Ozgur A, Nalbantoglu S, Karadag A
Mol Biol Rep. 2021; 48(4):3813-3825.
PMID: 33856604
DOI: 10.1007/s11033-021-06314-z.
Pilot Study to Detect Genes Involved in DNA Damage and Cancer in Humans: Potential Biomarkers of Exposure to E-Cigarette Aerosols.
Hamad S, Brinkman M, Tsai Y, Mellouk N, Cross K, Jaspers I
Genes (Basel). 2021; 12(3).
PMID: 33809907
PMC: 8004185.
DOI: 10.3390/genes12030448.
Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates.
Farkas M, Hashimoto H, Bi Y, Davuluri R, Resnick-Silverman L, Manfredi J
Nat Commun. 2021; 12(1):484.
PMID: 33473123
PMC: 7817693.
DOI: 10.1038/s41467-020-20783-z.
at the interface between intermediary metabolism and oncogenesis.
Pajares M
World J Biol Chem. 2017; 8(4):175-186.
PMID: 29225734
PMC: 5714802.
DOI: 10.4331/wjbc.v8.i4.175.
p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes.
Pappas K, Xu J, Zairis S, Resnick-Silverman L, Abate F, Steinbach N
Mol Cancer Res. 2017; 15(8):1051-1062.
PMID: 28483946
PMC: 5587155.
DOI: 10.1158/1541-7786.MCR-17-0089.
Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M, Quaas M, Nickel A, Engeland K
Oncotarget. 2015; 6(39):41402-17.
PMID: 26595675
PMC: 4747163.
DOI: 10.18632/oncotarget.6356.
The transcription factor p53: not a repressor, solely an activator.
Fischer M, Steiner L, Engeland K
Cell Cycle. 2014; 13(19):3037-58.
PMID: 25486564
PMC: 4612452.
DOI: 10.4161/15384101.2014.949083.
Battle against cancer: an everlasting saga of p53.
Hao Q, Cho W
Int J Mol Sci. 2014; 15(12):22109-27.
PMID: 25470027
PMC: 4284697.
DOI: 10.3390/ijms151222109.
Identification of two novel functional p53 responsive elements in the herpes simplex virus-1 genome.
Hsieh J, Kuta R, Armour C, Boehmer P
Virology. 2014; 460-461:45-54.
PMID: 25010269
PMC: 4090806.
DOI: 10.1016/j.virol.2014.04.019.
Activation of p53 transcriptional activity by SMRT: a histone deacetylase 3-independent function of a transcriptional corepressor.
Adikesavan A, Karmakar S, Pardo P, Wang L, Liu S, Li W
Mol Cell Biol. 2014; 34(7):1246-61.
PMID: 24449765
PMC: 3993559.
DOI: 10.1128/MCB.01216-13.
Smoking, p53 mutation, and lung cancer.
Gibbons D, Byers L, Kurie J
Mol Cancer Res. 2014; 12(1):3-13.
PMID: 24442106
PMC: 3925633.
DOI: 10.1158/1541-7786.MCR-13-0539.
Another fork in the road--life or death decisions by the tumour suppressor p53.
Carvajal L, Manfredi J
EMBO Rep. 2013; 14(5):414-21.
PMID: 23588418
PMC: 3642373.
DOI: 10.1038/embor.2013.25.
A single mutant, A276S of p53, turns the switch to apoptosis.
Reaz S, Mossalam M, Okal A, Lim C
Mol Pharm. 2013; 10(4):1350-9.
PMID: 23402381
PMC: 3658472.
DOI: 10.1021/mp300598k.
Using targeted transgenic reporter mice to study promoter-specific p53 transcriptional activity.
Goh A, Lim C, Chiam P, Li L, Mann M, Mann K
Proc Natl Acad Sci U S A. 2012; 109(5):1685-90.
PMID: 22307631
PMC: 3277193.
DOI: 10.1073/pnas.1114173109.